Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2024Open Access

Integrated clinical risk prediction of type 2 diabetes with a multifactorial polygenic risk score

View Full Paper
Ask AI
Bookmark
Share

Authors

SRScott C. RitchieHTHenry J. TaylorYLYujian Liang

Discussion

Loading...

Member takes

Overview

Randomized trial shows predictive power of polygenic risk scores for type 2 diabetes, suggesting improved screening strategies.

Key Points

  • MetaPRS demonstrates the strongest predictive power for type 2 diabetes, surpassing all individual risk factors except BMI.
  • Overall, the study evaluated 620,059 participants, including 50,572 T2D cases across diverse genetic ancestries.
  • Utilizing a meta-scoring approach, this analysis enhances T2D risk stratification when combined with existing clinical guidelines and scores for screening practices.   41   148   100   19   5   241   —    — .

Cite This Study

Ritchie et al. (2024) studied this question.

synapsesocial.com/papers/68e5b4dfb6db64358754d697https://doi.org/10.1101/2024.08.22.24312440
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Regularization and Variable Selection Via the Elastic Net2005 · 21,760 citations
  2. 2Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults2018 · 868 citations
  3. 3Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 20212023 · 4,700 citations
  4. 4The “All of Us” Research Program2019 · 873 citations
  5. 5Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations2024 · 215 citations